Mr. Eckhard G. Gunther Ph.D., is Vice President - Alliance Management of the company. He holds a degree in organic chemistry from the Martin-Luther University of Halle-Wittenberg, in Germany. With more than 25 years in the …
AEZS closed Monday's trading at $2.06, down 1.90%. In after-hours, the stock was up 4.37% to $2.15. Biogen (BIIB) and Alkermes plc (ALKS) have entered into a global license and collaboration agreement to develop and commercialize …
In order to select the right breakout stock one has to first calculate its support and resistance ... AEterna Zentaris Inc. (NASDAQ:AEZS) is a biopharmaceutical …
Investors in Aeterna Zentaris Inc. AEZS need to pay close attention to the stock based on moves in the options market lately. That is because the August 18 th, 2017 $7.50 Call had some of the highest implied volatility of all equity options …
Æterna Zentaris (NASDAQ: AEZS) has commenced an underwritten public offering ... The proposed Offering is subject to customary conditions, including the approval of The NASDAQ Stock Market ("NASDAQ") and the Toronto Stock
Shares of AEterna Zentaris Inc. (NASDAQ: AEZS), a specialty nano-cap bio-pharmaceutical company ... Other executives that acquired stock include the company's Senior Vice President and Chief Commercial Officer, Jude Dinges and Philip …
Investors in Aeterna Zentaris Inc. AEZS need to pay close attention to the stock based on moves in the options market lately. That is because the August 18 th, 2017 $7.50 Call had some of the highest implied volatility of all equity options …
Aeterna Zentaris Inc. AEZS was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent …
Will second time be the charm for Macrilen? AEZS closed Tuesday's trading at $1.02, down 2.86%. In after-hours, the stock zoomed 47.06% to $1.50. Aldeyra Therapeutics Inc. (ALDX) announced that the last patient has completed …